Gelteq Limited Ordinary Shares (GELS) - Cash Flow Conversion Efficiency

Latest as of September 2024: -0.020x

Based on the latest financial reports, Gelteq Limited Ordinary Shares (GELS) has a cash flow conversion efficiency ratio of -0.020x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-302.15K) by net assets ($15.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Gelteq Limited Ordinary Shares (GELS) balance sheet quality index to measure how much of total assets are equity-financed.

Gelteq Limited Ordinary Shares - Cash Flow Conversion Efficiency Trend (2023–2025)

This chart illustrates how Gelteq Limited Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore GELS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Gelteq Limited Ordinary Shares Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gelteq Limited Ordinary Shares ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Itech Minerals Ltd
AU:ITM
-0.014x
JPMorgan Indian Inv Trust
LSE:JII
-0.006x
Global Interactive Technologies, Inc
NASDAQ:GITS
-0.032x
Intan Baruprana Finance Tbk
JK:IBFN
-0.021x
Chewathai Public Company Limited
BK:CHEWA
0.130x
North Stawell Minerals Ltd
AU:NSM
-0.045x
In-Touch Survey Systems Ltd.
V:INX
-0.027x
REGENER8 Resources NL
AU:R8R
-0.120x

Annual Cash Flow Conversion Efficiency for Gelteq Limited Ordinary Shares (2023–2025)

The table below shows the annual cash flow conversion efficiency of Gelteq Limited Ordinary Shares from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see Gelteq Limited Ordinary Shares (GELS) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $15.80 Million $-5.52 Million -0.349x -393.22%
2024-06-30 $15.11 Million $-1.07 Million -0.071x +25.35%
2023-06-30 $18.66 Million $-1.77 Million -0.095x --

About Gelteq Limited Ordinary Shares

NASDAQ:GELS USA Drug Manufacturers - Specialty & Generic
Market Cap
$5.57 Million
Market Cap Rank
#28328 Global
#5739 in USA
Share Price
$0.52
Change (1 day)
-5.63%
52-Week Range
$0.39 - $1.68
All Time High
$4.79
About

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Austra… Read more